Source comparison
Cartalax vs Epithalon — Peptide Comparison | Real Peptides
Research published in the International Journal of Molecular Sciences found that short bioregulatory peptides (2–4 amino acids) demonstrate tissue-specific gene expression modulation at nanomolar concentrations. Meaning that despite structural similarities, co
This comparison does not assign a generated winner or score.
- Research published in the International Journal of Molecular Sciences found that short bioregulatory peptides (2–4 amino acids) demonstrate tissue-specific gene expression modulation at nanomolar concentrations. Meaning that despite structural similarities, compounds like Cartalax and Epithalon produce entirely different biological outcomes. The difference between Cartalax and Epithalon isn't subtle preference. It's fundamental mechanism: one regulates existing cellular function in gastrointestinal tissue, the other extends replicative lifespan by activating telomerase in multiple cell types. Choose the wrong peptide and your longevity research protocol measures outcomes unrelated to your hypothesis.
- Our team has reviewed procurement decisions across hundreds of institutional and private research protocols. The confusion between these two peptides is consistent every time. Both are marketed under the umbrella term 'anti-aging peptides,' but their biological targets, pathways, and experimental applications share almost no overlap.
- What is the difference between Cartalax and Epithalon?
- Cartalax is a tetrapeptide (Ala-Glu-Asp-Gly) that modulates gene expression in gastric and intestinal tissue through chromatin remodelling, while Epithalon (also called Epitalon) is a tetrapeptide (Ala-Glu-Asp-Gly) that activates telomerase. The enzyme responsible for extending telomere length and cellular replication capacity. Cartalax demonstrates tissue-specific regulatory effects on gastrointestinal mucosa; Epithalon operates systemically to influence cellular senescence pathways across multiple tissue types.
- Most research protocols conflate these peptides because both originated from the work of Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology and both consist of four amino acids. What that surface-level similarity misses: Cartalax binds to specific DNA sequences in gastric epithelial cells to upregulate protective protein synthesis, while Epithalon works through the pineal gland to stimulate telomerase activity. Two entirely separate biological systems. This article covers the structural and mechanistic differences, experimental applications where each compound is appropriate, and what preparation mistakes compromise peptide integrity for both.